Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review.

Rashki Kemmak, Asma; Abutorabi, Ali; Alipour, Vahid

Rashki Kemmak, Asma; Abutorabi, Ali; Alipour, Vahid.

Affiliation

Rashki Kemmak A; Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Abutorabi A; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. Abutorabi.a@iums.ac.ir.
Alipour V; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Clin Drug Investig ; 40(8): 715-725, 2020 Aug.

Article in En | MEDLINE | ID: mdl-32578155

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enoxaparin / Arthroplasty, Replacement, Hip / Arthroplasty, Replacement, Knee / Venous Thromboembolism / Rivaroxaban / Anticoagulants Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limits: Humans / Middle aged Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Irán Country of publication: Nueva Zelanda

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google